MedTrace Logo

Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam

NCT07501793 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 800000

Last updated 2026-04-13

No results posted yet for this study

Summary

The study aims to retrospectively describe the demographic characteristics, comorbidity profiles, vaccination history and vaccination patterns of all individuals who have received at least one dose of TAK-003 (Qdenga) dengue vaccine at all VNVC centers between September 26, 2024 and September 30, 2025. The study will utilize existing data from the VNVC immunization database. No new data collection or direct participant contact will occur.

Conditions

  • Dengue

Sponsors & Collaborators

  • Vietnam Vaccine Joint Stock Company

    collaborator UNKNOWN

  • Takeda

    collaborator INDUSTRY

  • Tam Anh Research Institute

    lead OTHER

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-16
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07501793 on ClinicalTrials.gov